Balyasny Asset Management LLC Amneal Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $81,679 - $135,836	29,594 New	29,594 $124,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $69,313 - $131,864	-24,151 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $59,411 - $129,207	24,151 New	24,151 $84,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $75,189 - $233,121	-32,834 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $613,648 - $1.36 Million	-95,287 Reduced 74.37%	32,834 $235,000
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $719,381 - $899,378	60,605 Added 89.76%	128,121 $1.82 Million
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $64,900 - $106,547	-4,958 Reduced 6.84%	67,516 $913,000
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $1.19 Million - $1.76 Million	72,474 New	72,474 $1.61 Million

193

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.32B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.